ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2246 • 2018 ACR/ARHP Annual Meeting

    Insulin: Genetic and Physiological Influences on Human Uric Acid Homeostasis

    David B. Mount1, Tony R. Merriman2 and Asim Mandal1, 1Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2University of Otago, Dunedin, New Zealand

    Background/Purpose: Insulin plays a key role in the genesis of hyperuricemia. In particular, hyperinsulinemia in metabolic syndrome is inversely correlated with urinary uric acid (UA)…
  • Abstract Number: 2247 • 2018 ACR/ARHP Annual Meeting

    Predictors of End-Stage Renal Disease (ESRD) in Gout Patients and General Population (GP) Controls – a Role for Interstitial Nephritis, Urate Nephropathy?

    Martin Joelsson1, Lennart Jacobsson1 and Mats Dehlin2, 1Dept of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, Sweden, Gothenburg, Sweden, 2Department of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, Sweden, Gothenburg, Sweden

    Background/Purpose: Decreased renal excretion of urate is an established risk factor for hyperuricemia, whereas it is less clear if hyperuricemia or gout predict impaired kidney…
  • Abstract Number: 2248 • 2018 ACR/ARHP Annual Meeting

    Genetic Variants Identify Interleukin 37 As an Important Anti-Inflammatory Cytokine in Gout in Humans

    Viola Klück1, Rosanne C. van Deuren1, Amara Shaukat2, Maartje Cleophas1, Tania O. Crisan3, Nicola Dalbeth4, Lisa K. Stamp5, Tim Jansen6, Matthijs Janssen6, Alexander Hoischen1, Frank van de Veerdonk7, Mihai Netea1, Charles Dinarello8, Elan Z. Eisenmesser9, Vassili Kalabokis10, Soohyun Kim11, Tony R. Merriman12 and Leo .A.B. Joosten1, 1Experimental Internal Medicine, Radboud Institute of Molecular Life Sciences, Nijmegen, Netherlands, 2University of Otago, Dunedin, New Zealand, 3Medical Genetics, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania, 4Bone Rsch Grp/Dept of Med, University of Auckland, Auckland, New Zealand, 5Department of Medicine, University of Otago, Christchurch, New Zealand, 6VieCuri Medical Center, Venlo, Netherlands, 7Department of General Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands, 8Department of Medicine, Division of Infectious Diseases, University of Colorado, Denver, CO, 9Department of Biochemistry and Molecular Genetics, University of Colorado Denver, Aurora, CO, 10R&D Systems, BioTechne, Inc., Minneapolis, MN, 11Laboratory of Cytokine Immunology, Konkuk University, Seoul, Korea, Republic of (South), 12Department of Biochemistry, School of Medical Sciences, University of Otago, Dunedin, New Zealand

    Background/Purpose: During a gout flare monosodium urate (MSU) crystals induce, in the presence of a secondary stimulus, acute joint inflammation characterized by the recruitment of…
  • Abstract Number: 2249 • 2018 ACR/ARHP Annual Meeting

    Not Just a Swollen Big Toe: Increasing All-Cause Hospitalizations in Patients with Gout in the United States: 1993–2014

    Gurkirpal Singh1 and Alka Mithal2, 1Stanford University School of Medicine, Woodside, CA, 2ICORE, Woodside, CA

    Background/Purpose: Gout is a disorder of uric acid metabolism and often presents as acute severe joint pain. However, several recent studies have highlighted systemic complications…
  • Abstract Number: 2250 • 2018 ACR/ARHP Annual Meeting

    Mitigation of Inflammation Induced By Monosodium Urate Crystals in Mice By Treatment with Svp-Rapamycin

    Pallavi Kolte, Robert LaMothe, Joseph Ferrari, Sheldon Leung, Wesley DeHaan Ph.D., Earl Sands and Takashi Kei Kishimoto, Selecta Biosciences, Watertown, MA

    Background/Purpose:  Initiation of urate-lowering therapies is typically associated with an increase in gout flares due to mobilization of pro-inflammatory urate crystals.  SEL-212 is a novel…
  • Abstract Number: 2251 • 2018 ACR/ARHP Annual Meeting

    Calcific Tendonitis of the Rotator Cuff: Do We Need Steroid Injection after Ultrasound Guided Percutaneous Lavage? Results of a 12-Months Double-Blind Randomized Controlled Study

    Christelle Darrieutort-Laffite1, Stéphane Varin2, Guillaume Coiffier3, Jean-David Albert3, Gregoire Cormier2 and Benoit Le Goff1, 1Rheumatology, Nantes University Hospital, Nantes, France, 2Rheumatology, La Roche-Sur-Yon Hospital, La Roche-Sur-Yon, France, 3Rheumatology, Rennes University Hospital, Rennes, France

    Background/Purpose: Rotator cuff calcific tendinopathy is a common condition causing up to 20% of the painful shoulder. Ultrasound-guided percutaneous lavage (UGPL) is indicated after failure…
  • Abstract Number: 2252 • 2018 ACR/ARHP Annual Meeting

    Serum Urate Ant Its Clearance in Patients with Chronic Kidney Disease Under Peritoneal Dialysis

    Claudia Diez1, Javier Pérez-Contreras1,2 and Mariano Andrés1,3, 1Departamento de Medicina Clínica, Universidad Miguel Hernández, Alicante, Spain, 2Servicio de Nefrología, Hospital General Universitario de Alicante-ISABIAL, Alicante, Spain, 3Hospital General Universitario de Alicante-ISABIAL, Alicante, Spain

    Background/Purpose: Hyperuricemia and gout are common in patients with chronic kidney disease (CKD), some ultimately requiring replacement therapy. Serum urate (SU) levels appear to achieve…
  • Abstract Number: 2253 • 2018 ACR/ARHP Annual Meeting

    Cardiovascular Disease, Other Purported Risk Factors, and Allopurinol-Associated Severe Cutaneous Adverse Reactions: A General Population-Based Cohort Study

    Na Lu1, Chio Yokose2, Hui Xie1,3, Gloria Li1, Sharan K. Rai4,5, Seoyoung C. Kim6 and Hyon K. Choi2, 1Arthritis Research Canada, Richmond, BC, Canada, 2Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA, 3Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada, 4Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, 5Graduate School of Arts and Sciences, Harvard University, Cambridge, MA, 6Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: A recent US Medicaid study found that in addition to certain races (Asians and Blacks), older age, female sex, chronic kidney disease (CKD), and…
  • Abstract Number: 2254 • 2018 ACR/ARHP Annual Meeting

    Update of SEL-212 Phase 2 Clinical Data in Symptomatic Gout Patients: Svp-Rapamycin Combined with Pegadricase Mitigates Immunogenicity and Enables Sustained Reduction of Serum Uric Acid Levels, Low Rate of Gout Flares and Monthly Dosing

    Earl Sands1, Alan J. Kivitz2, Wesley DeHaan Ph.D.1, Lloyd Johnston1 and Takashi Kei Kishimoto1, 1Selecta Biosciences, Watertown, MA, 2Altoona Center for Clinical Research, Duncansville, PA

    Background/Purpose:  Pegylated uricases are promising therapies for the treatment of severe chronic gout, but are limited by their immunogenicity.  We have previously shown that synthetic…
  • Abstract Number: 2255 • 2018 ACR/ARHP Annual Meeting

    Increased Cost Burden in an Early Diagnosed Cohort of Uncontrolled Versus Controlled Gout: Analysis of a Large US Payer Database

    Brian LaMoreaux1, Megan Francis-Sedlak2 and Robert J Holt2, 1Horizon Pharma USA, Inc, Lake Forest, IL, 2Horizon Pharma USA, Inc., Lake Forest, IL

    Background/Purpose: Gout is a progressive systemic inflammatory disease that is widely prevalent, estimated to effect 3.9% or 8.3 million people of the United State (US)…
  • Abstract Number: 2256 • 2018 ACR/ARHP Annual Meeting

    Rheumatic Diseases Associated with Neuromyelitis Optica Spectrum Disorders (NMOSD): Prevalence, Clinical, Laboratory and Imaging Characteristics

    Milena Rodriguez Alvarez1, Su Zhaz Leon1, Fernando Cuascut2, Naureen Kabani3, Joshy Pathiparampil3, Kristaq Koci4, Manjeet Bhamra5, Latoya Freeman4, Alexandra Kreps6, Justin Levinson6, Sophia Francis6, Vinodkumar Velayndhan6, Steve Xie7, Abhimanyu Amarnani6, Helen Valsamis8, Yaacov Anziska6, Ellen M. Ginzler9 and Isabel M. McFarlane9, 1Rheumatology, SUNY Downstate, Brooklyn, NY, 2Neurology, SUNY Downstate, Brooklyn, NY, 3Internal Medicine, SUNY Downstate Medical Center, Brooklyn, NY, 4Medicine, SUNY Downstate Medical Center, Brooklyn, NY, 5Medicine, SUNY Downstate, Brooklyn, NY, 6SUNY Downstate, Brooklyn, NY, 7NYC Health + Hospitals Kings County, Brooklyn, NY, 8Neurology, NYC Health + Hospitals Kings County, Brooklyn, NY, 9Rheumatology, SUNY Downstate Medical Center, Brooklyn, NY

     Background/Purpose: NMOSD are autoimmune disorders characterized by optic neuritis (ON), longitudinal extensive transverse myelitis (LETM), and other clinical features. Aquaporin 4 antibodies (AQP4 Ab) have…
  • Abstract Number: 2257 • 2018 ACR/ARHP Annual Meeting

    Prevalence and Distinct Clinical Phenotype of Concomitant Sarcoidosis in Other Autoimmune Rheumatic Diseases

    Kristina E.N. Clark1, Huw Beynon2, Christopher P. Denton3 and Voon H. Ong4, 1Centre of Rheumatology and Connective Tissue Diseases, University College London, London, United Kingdom, 2Department of Rheumatology, Royal Free Hospital, London, United Kingdom, 3UCL Division of Medicine, Royal Free Campus, London, United Kingdom, 4Division of Medicine, University College London, London, United Kingdom

    Background/Purpose: Lung involvement is common in both sarcoidosis (up to 90%) and autoimmune rheumatic diseases (ARDs). Case reports have suggested distinct clinical manifestations when sarcoidosis…
  • Abstract Number: 2258 • 2018 ACR/ARHP Annual Meeting

    Defining Characteristics of Patients with Overlap between Sarcoidosis and Connective Tissue Diseases

    Mugdha Agrawal and Colin Ligon, Department of Medicine; Division of Rheumatology, University of Pennsylvania, Philadelphia, PA

    Background/Purpose:   Sarcoidosis has been suggested to occur with connective tissue diseases (CTDs) more frequently than would be expected by chance, but the types, relative…
  • Abstract Number: 2259 • 2018 ACR/ARHP Annual Meeting

    BONE Sarcoidosis: A French Case Control Study

    Imen Ben hassine1, Christopher Rein2, Cloé Comarmond3, Catherine Chapelon-Abric4, Nathalie Saidenberg5, Benoit Meunier6, Nicolas Schleinitz7, Noémie Chanson8, Marc Scherlinger9, Christophe Richez10, Sandrine Hirschi11, Matthieu Groh12, Hervé Devilliers13, David Saadoun14, Laurent Arnaud15 and Patrice Cacoub16, 1Internal Medicine and Clinical Immunology, Pitié-Salpêtrière Hospital, Paris, France, 2Rheumatology, UPMC GRC08, Paris 06 University, Pitié Salpétrière Hospital, Paris, France, 3DHU 2iB Internal Medicine Referal Center for Autoimmune diseases Pitie Hospital, Paris, France, 4AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France, Paris, France, 5Rheumatology, CHU Avicennes, Bobigny, France, 6Internal Medicine, CHU La Timone, Marseille, France, 7La Timone University Hospital, Marseille, France, 8Internal Medicine, Hopital Bicetre, LE KREMLIN BICETRE, France, 9Rheumatology, UMR CNRS 5164 - Immunoconcept, France, Bordeaux, France, 10UMR CNRS 5164 - Immunoconcept, Bordeaux, France, 11Pneumology, CHU de Strasbourg, Strasbourg, France, 12Internal Medicine, Foch, Suresnes, France, 13Service de Médecine Interne et Maladies Systémiques, CHU de Dijon, Dijon, France, 14Sorbonne Universités, UPMC Univ Paris 06, UMR 7211, and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), F-75005, Paris, France; INSERM, UMR_S 959, F-75013, Paris, France; CNRS, FRE3632, F-75005, Paris, France; AP-HP, Groupe Hospitalier Pitié, Paris, France, 15Department of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, 16Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Pitié-Salpêtrière, Paris, France

    Background/Purpose: Osseous manifestations of sarcoidosis are uncommon. We aimed to characterize clinical presentation, distribution of lesions, treatment, and outcomes of bone sarcoidosis. Methods: A French…
  • Abstract Number: 2260 • 2018 ACR/ARHP Annual Meeting

    Musculoskeletal Sarcoidosis: A 15-Year Experience from a Tertiary Care Center in the US

    Sanjeev Patil1, Masumi Arakane2, Sreedevi Jenigiri3, Elizabeth Field4 and Namrata Singh5, 1Rheumatology, University of Iowa Hospitals and Clinics, Iowa City, IA, 2University of Iowa Hospitals and Clinics, Iowa City, IA, 3Iowa City VA Healthcare System, Iowa City, IA, 4Iowa City VA, Iowa City, IA, 5Internal Medicine, Iowa City VA Medical Center and University of Iowa, Iowa City, IA

    Background/Purpose: Sarcoidosis, a systemic disease characterized by non-caseating granulomas within the affected organs. Less than 10% of cases manifest as musculoskeletal (MSK) involvement of joints,…
  • « Previous Page
  • 1
  • …
  • 1334
  • 1335
  • 1336
  • 1337
  • 1338
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology